New investors or those with lower-than-planned exposure should add US-oriented funds through SIPs.
Investing in US equities has proved rewarding for Indian investors during a period of muted performance by domestic equities.
While Indian flexicap funds returned 3.6 per cent over the past year, schemes investing in US markets delivered far higher gains.
The S&P 500 index and the Nasdaq-100 have returned 18.5 per cent and 27.4 per cent, respectively.
The US remains a robust and well-regulated market.
"US equity markets have delivered strong returns over the past year, led by resilient earnings, AI -driven productivity optimism, and a robust economy," says Pratik Oswal, head of passive funds, Motilal Oswal Asset Management Company.
"While valuations are elevated in some segments, particularly largecap tech, the US remains the world's most innovative and diversified economy," Oswal adds.
Strong momentum
US equities may continue to perform well as the US Federal Reserve announced another policy rate cut on October 29.
Trade tensions appear to be easing.
"Tailwinds such as ongoing AI or productivity gains, consumer tech, cutting-edge healthcare solutions and health-tech with resilient domestic demand and rate cut can support equities," says Abhishek Tiwari, chief executive officer, PGIM India Asset Management.
"The growing strength of the US technology story, especially developments in AI and related innovations, is a major positive driver for US equity markets," says Niranjan Avasthi, senior vice president, Edelweiss Mutual Fund.
Valuation, inflation risk
Investors should remain mindful of headwinds when considering allocations to US-focused funds. Valuations remain elevated, especially in technology stocks.
"Investors should be prepared for bouts of volatility. Expensive valuations and renewed inflationary concerns, possibly exacerbated by higher tariffs, pose potential risks," says Avasthi.
Narrow indices riskier
Concentrated, tech-heavy indices carry greater risk than diversified benchmarks.
"Narrower, tech-heavy indices such as Nasdaq-100 or the FAANG basket have delivered outsized returns, but they come with higher volatility and concentration risk.
"Broader indices like the S&P 500 offer balanced exposure across sectors and tend to be more stable over cycles," says Oswal.
Focus on asset allocation
Investors whose US allocation has exceeded target levels should rebalance through profit booking or by adding to other asset classes.
"Treat US or global equity funds as a long-term diversifier, not a performance chase.
"Build positions gradually, and size AI-tech concentration carefully. Rebalance to target weights.
"If US exposure has run ahead, trim gains rather than exit completely.
"Maintain discipline and don't stop systematic investment plans (SIPs) during corrections," says Tiwari.
"Partial profit booking may be considered only if the allocation to US equities has become disproportionately high relative to one's overall portfolio," says Avasthi.
New investors can begin slowly
New investors or those with lower-than-planned exposure should add US-oriented funds through SIPs. Avoid lump-sum deployment.
"New investors can consider entering gradually through SIPs, keeping a five-to-seven-year horizon," says Oswal.
"Existing investors can continue holding if their allocation aligns with long-term goals. A 10 to 15 per cent allocation to international or US-focused funds is ideal for most diversified portfolios," adds Oswal.
Build overseas exposure with the intention to diversify.
"Limit allocation to 10 to 20 per cent of the equity portfolio in global funds (with a US tilt) as a pragmatic diversification band, calibrated to risk tolerance.
"Have a minimum five-to-seven-year horizon to ride out economic cycles and currency effects. Rebalance annually.
"Lower long-term correlation with domestic markets supports diversification benefits," says Tiwari.
Disclaimer: This article is meant for information purposes only. This article and information do not constitute a distribution, an endorsement, an investment advice, an offer to buy or sell or the solicitation of an offer to buy or sell any securities/schemes or any other financial products/investment products mentioned in this article to influence the opinion or behaviour of the investors/recipients.
Any use of the information/any investment and investment related decisions of the investors/recipients are at their sole discretion and risk. Any advice herein is made on a general basis and does not take into account the specific investment objectives of the specific person or group of persons. Opinions expressed herein are subject to change without notice.
Feature Presentation: Ashish Narsale/Rediff
© 2025